Jennison Associates LLC Cyma Bay Therapeutics, Inc. Transaction History

Jennison Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$12.63 - $24.47 $5.52 Million - $10.7 Million	437,437 Added 12.3%	3,992,711 $94.3 Million
Q3 2023 Oct 31, 2023	BUY	$10.86 - $17.62 $20.5 Million - $33.2 Million	1,883,742 Added 112.7%	3,555,274 $53 Million
Q2 2023 Aug 03, 2023	BUY	$7.47 - $10.95 $7.83 Million - $11.5 Million	1,047,869 Added 168.02%	1,671,532 $18.3 Million
Q1 2023 Apr 26, 2023	BUY	$5.88 - $9.59 $3.67 Million - $5.98 Million	623,663 New	623,663 $5.44 Million

1.88M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.